Bellevue Group’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.03M Sell
85,438
-5,753
-6% -$204K 0.07% 89
2025
Q1
$3.09M Sell
91,191
-76,150
-46% -$2.58M 0.07% 95
2024
Q4
$5.45M Sell
167,341
-1,793
-1% -$58.3K 0.1% 94
2024
Q3
$8.24M Sell
169,134
-200,136
-54% -$9.75M 0.13% 91
2024
Q2
$16.4M Buy
369,270
+76,000
+26% +$3.37M 0.27% 84
2024
Q1
$16.4M Buy
293,270
+91,516
+45% +$5.13M 0.25% 83
2023
Q4
$12.1M Sell
201,754
-76,400
-27% -$4.6M 0.19% 84
2023
Q3
$18.7M Buy
278,154
+2,400
+0.9% +$161K 0.3% 75
2023
Q2
$19M Sell
275,754
-231,500
-46% -$16M 0.27% 81
2023
Q1
$24.5M Buy
507,254
+152,465
+43% +$7.35M 0.35% 71
2022
Q4
$17.7M Sell
354,789
-270,672
-43% -$13.5M 0.24% 89
2022
Q3
$25.5M Sell
625,461
-4,978
-0.8% -$203K 0.37% 72
2022
Q2
$34.7M Sell
630,439
-29,630
-4% -$1.63M 0.49% 59
2022
Q1
$24M Buy
660,069
+2,413
+0.4% +$87.7K 0.28% 89
2021
Q4
$30.7M Buy
657,656
+371,100
+130% +$17.3M 0.32% 86
2021
Q3
$14.5M Sell
286,556
-103,607
-27% -$5.24M 0.15% 105
2021
Q2
$16M Sell
390,163
-213,080
-35% -$8.75M 0.16% 113
2021
Q1
$17.5M Buy
603,243
+186,902
+45% +$5.42M 0.19% 103
2020
Q4
$11.7M Buy
+416,341
New +$11.7M 0.13% 113
2020
Q3
Sell
-134,261
Closed -$5.71M 219
2020
Q2
$5.71M Buy
+134,261
New +$5.71M 0.08% 122